Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Mucinous Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00052585
What this trial is testing

Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumMucinous Adenocarcinoma of the Colon+7 more
National Cancer Institute (NCI) 50
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Not applicableUnknownNCT01995942
What this trial is testing

Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial

Who this might be right for
AdenocarcinomaRectal DiseasesColorectal Neoplasms+13 more
Royal Marsden NHS Foundation Trust 246
Large-scale testing (Phase 3)UnknownNCT00002896
What this trial is testing

Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer

Who this might be right for
Colorectal Cancer
European Institute of Oncology 774
Early research (Phase 1)Ended earlyNCT01197664
What this trial is testing

Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery

Who this might be right for
Mucinous Adenocarcinoma of the RectumStage IIA Rectal CancerStage IIB Rectal Cancer+3 more
Wake Forest University Health Sciences 2
Not applicableStudy completedNCT06978595
What this trial is testing

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies

Who this might be right for
Colorectal CarcinomaCancerSignet Ring Adenocarcinoma of the Colon
asmaa salama ibrahim 8,171
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Very early researchEnded earlyNCT00835679
What this trial is testing

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

Who this might be right for
Liver MetastasesMucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum+6 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Ended earlyNCT03693846
What this trial is testing

Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the Rectum
Abramson Cancer Center at Penn Medicine 11
Post-approval studies (Phase 4)Looking for participantsNCT04373564
What this trial is testing

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Who this might be right for
Motor FunctionCognitive FunctionContrast Media
Guerbet 2,076
Early research (Phase 1)Study completedNCT04088786
What this trial is testing

Phase I Trial HIPEC With Nal-irinotecan

Who this might be right for
Peritoneal CancerPseudomyxoma PeritoneiMucinous Adenocarcinoma+5 more
Stony Brook University 18
Testing effectiveness (Phase 2)UnknownNCT01037049
What this trial is testing

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Who this might be right for
Adenocarcinoma of the RectumAdenocarcinomaAdenocarcinoma, Mucinous+14 more
Royal Marsden NHS Foundation Trust 237
Early research (Phase 1)Study completedNCT02232152
What this trial is testing

CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+13 more
Wake Forest University Health Sciences 19
Early research (Phase 1)Study completedNCT04853017
What this trial is testing

ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors

Who this might be right for
Minimal Residual DiseaseKRAS G12DKRAS G12R+9 more
Elicio Therapeutics 25
Early research (Phase 1)Study completedNCT02270606
What this trial is testing

Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the RectumRecurrent Rectal CancerSignet Ring Adenocarcinoma of the Rectum+7 more
Virginia Commonwealth University 14
Not applicableUnknownNCT04716257
What this trial is testing

A Prospective, Multi-center, Real-world Study of Ovarian Metastatic Colorectal Cancer Patients

Who this might be right for
Ovarian MetastasisColorectal Cancer
West China Hospital 400
Testing effectiveness (Phase 2)Study completedNCT03602079
What this trial is testing

Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene

Who this might be right for
HER2-positive Breast CancerHER2 Gene MutationHER-2 Gene Amplification+41 more
Klus Pharma Inc. 49
Testing effectiveness (Phase 2)Looking for participantsNCT04779554
What this trial is testing

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Who this might be right for
Peritoneal Carcinomatosis
Prakash Pandalai 100
Not applicableEnded earlyNCT01934179
What this trial is testing

Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumSignet Ring Adenocarcinoma of the Colon+9 more
Fox Chase Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT01079780
What this trial is testing

Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy

Who this might be right for
Colorectal Cancer
Eastern Cooperative Oncology Group 136
Next Page